World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
17121
World Ranking
5135
National Ranking
335

Overview

Naoya Fujita is affiliated with the Japanese Foundation For Cancer Research in Japan. Their research primarily addresses key areas within medicine and biochemistry, genetics, and molecular biology, focusing on oncology, molecular biology, pulmonary and respiratory medicine, immunology, and biomedical engineering.

Their scholarly contributions include an emphasis on lung cancer treatments and mutations, lung cancer research studies, cancer cells and metastasis, 3D printing in biomedical research, cancer research and treatments, the complement system in diseases, and PI3K/AKT/mTOR signaling in cancer.

Some recent publications by Naoya Fujita include:

  • Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1, 2020, Proceedings of the National Academy of Sciences
  • Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer, 2021, Nature Communications
  • The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab, 2020, Pediatric Nephrology
  • Drug resistance mechanisms in Japanese anaplastic lymphoma kinase-positive non-small cell lung cancer and the clinical responses based on the resistant mechanisms, 2020, Cancer Science
  • Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylation, 2021, JCI Insight

Frequent co-authors collaborating with Naoya Fujita include Ryohei Katayama, Makoto Nishio, Noriko Yanagitani, Satoshi Takagi, and Ken Uchibori.

Their work has been published repeatedly in several scientific venues, including:

  • Cancer Science
  • npj Precision Oncology
  • Cancer Research
  • Pediatric Nephrology
  • Oncogene

Best Publications

  • Modulation of Akt kinase activity by binding to Hsp90

    Saori Sato;Naoya Fujita;Takashi Tsuruo

  • The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer

    Luc Friboulet;Nanxin Li;Ryohei Katayama;Christian C. Lee

  • Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

    Takashi Tsuruo;Mikihiko Naito;Akihiro Tomida;Naoya Fujita

  • Domain Mapping Studies Reveal That the M Domain of hsp90 Serves as a Molecular Scaffold to Regulate Akt-Dependent Phosphorylation of Endothelial Nitric Oxide Synthase and NO Release

    Jason Fontana;David Fulton;Yan Chen;Todd A. Fairchild

  • Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow

    Mika Shimonaka;Mika Shimonaka;Koko Katagiri;Toshinori Nakayama;Naoya Fujita

  • Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.

    Naoya Fujita;Saori Sato;Kazuhiro Katayama;Takashi Tsuruo;Takashi Tsuruo

  • Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

    Ken Uchibori;Naohiko Inase;Mitsugu Araki;Mayumi Kamada

  • Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels

    Daisuke Morishita;Ryohei Katayama;Kazuhisa Sekimizu;Takashi Tsuruo

  • Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors

    Yukinari Kato;Naoya Fujita;Akiko Kunita;Shigeo Sato

  • Caspase-mediated cleavage of p21Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis.

    Yongke Zhang;Naoya Fujita;Takashi Tsuruo;Takashi Tsuruo

  • Two novel ALK mutations mediate acquired resistance to the next generation ALK inhibitor alectinib

    Ryohei Katayama;Luc Friboulet;Sumie Koike;Elizabeth L. Lockerman

  • Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis.

    Tetsuo Mashima;Mikihiko Naito;Naoya Fujita;Kohji Noguchi

  • Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)

    Saori Sato;Naoya Fujita;Takashi Tsuruo;Takashi Tsuruo

  • Involvement of Hsp90 in signaling and stability of 3-phosphoinositide-dependent kinase-1.

    Naoya Fujita;Saori Sato;Atsushi Ishida;Takashi Tsuruo;Takashi Tsuruo

  • Enhanced Expression of Aggrus (T1alpha/Podoplanin), a Platelet-Aggregation-Inducing Factor in Lung Squamous Cell Carcinoma

    Yukinari Kato;Mika Kaneko;Mika Kaneko;Makoto Sata;Naoya Fujita

  • Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization

    Naoya Fujita;Saori Sato;Takashi Tsuruo;Takashi Tsuruo

  • Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.

    Satoshi Takagi;Shigeo Sato;Tomoko Oh-hara;Miho Takami

  • Cytotoxic Activity of Tivantinib (ARQ 197) Is Not Due Solely to c-MET Inhibition

    Ryohei Katayama;Aki Aoyama;Takao Yamori;Jie Qi

  • Cabozantinib Overcomes Crizotinib Resistance in ROS1 Fusion–Positive Cancer

    Ryohei Katayama;Yuka Kobayashi;Yuka Kobayashi;Luc Friboulet;Elizabeth L. Lockerman

  • Binding and Phosphorylation of Par-4 by Akt Is Essential for Cancer Cell Survival

    Anindya Goswami;Ravshan Burikhanov;Aurelie de Thonel;Naoya Fujita

Frequent Co-Authors

Takashi Tsuruo
Takashi Tsuruo Japanese Foundation For Cancer Research
Takashi Tsuruo
Takashi Tsuruo Japanese Foundation For Cancer Research
Yukinari Kato
Yukinari Kato Tohoku University
Mikihiko Naito
Mikihiko Naito University of Tokyo
Alice T. Shaw
Alice T. Shaw Harvard University
Jeffrey A. Engelman
Jeffrey A. Engelman Novartis Institutes for BioMedical Research (NIBR)
Hiroyuki Arai
Hiroyuki Arai University of Tokyo
Jean-François Beaulieu
Jean-François Beaulieu Université de Sherbrooke
Yoshikazu Sugimoto
Yoshikazu Sugimoto Keio University
Justin F. Gainor
Justin F. Gainor Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Naoya Fujita

Trending Scientists